BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3759662)

  • 21. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
    Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 19-Deformyl-4'-deoxydesmycosin (TMC-016): synthesis and biological properties of a unique 16-membered macrolide antibiotic.
    Fujiwara T; Watanabe H; Kogami Y; Shiritani Y; Sakakibara H
    J Antibiot (Tokyo); 1989 Jun; 42(6):903-12. PubMed ID: 2500413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facile synthesis of tilmicosin and tylosin related haptens for use as protein conjugates.
    Creemer LC; Beier RC; Kiehl DE
    J Antibiot (Tokyo); 2003 May; 56(5):481-7. PubMed ID: 12870814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peptide derivatives of tylosin-related macrolides].
    Korshunova GA; Sumbatian NV; Fedorova NV; Kuznetsova IV; Shishkina AV; Bogdanov AA
    Bioorg Khim; 2007; 33(2):235-44. PubMed ID: 17476984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical modification of deltamycins. I. 4''-O-acyl analogs of deltamycins.
    Shimauchi Y; Hori K; Sakamoto M; Mutoh Y; Fukagawa Y; Hori S; Ishikura T; Lein J
    J Antibiot (Tokyo); 1980 Mar; 33(3):284-92. PubMed ID: 7380741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro antibiotic activity of 16-membered 9-O-arylalkyloxime macrolides.
    Fu H; Marquez S; Gu X; Katz L; Myles DC
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1259-66. PubMed ID: 16343900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical modification of tylosin. Thioether derivatives of tylosin and demycarosyltylosin.
    Omura S; Matsubara H; Tsuzuki K; Nakagawa A
    J Antibiot (Tokyo); 1984 Sep; 37(9):1007-15. PubMed ID: 6501102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel 4'-substituted 16-membered ring macrolide antibiotics derived from leucomycins.
    Wang Z; Jian T; Phan LT; Or YS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):519-21. PubMed ID: 14698194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme immunoassay for macrolide antibiotics: characterization of an antibody to 23-amino-O-mycaminosyltylonolide.
    Yao RC; Mahoney DF
    Appl Environ Microbiol; 1989 Jun; 55(6):1507-11. PubMed ID: 2764563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syntheses of derivatives of 4'-deoxymycaminosyl tylonolide and mycaminosyl tylonolide modified AT C-23.
    Tanaka A; Tsuchiya T; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1377-80. PubMed ID: 7309634
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
    Ose EE
    J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semisynthetic macrolide antibacterials derived from tylosin. Synthesis and structure-activity relationships of novel desmycosin analogues.
    Mutak S; Marsić N; Kramarić MD; Pavlović D
    J Med Chem; 2004 Jan; 47(2):411-31. PubMed ID: 14711312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 4'-deoxymycaminosyl tylonolide.
    Tanaka A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1374-6. PubMed ID: 7309633
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel leucomycin analogues modified at the C-3 position. I. Epimerization and methylation of the 3-hydroxyl group.
    Furuuchi T; Kurihara K; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2003 Apr; 56(4):399-414. PubMed ID: 12817814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses of 4'-deoxy-demycarosyl tylosin and its analogues.
    Tanaka A; Watanabe A; Tsuchiya T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1381-4. PubMed ID: 7309635
    [No Abstract]   [Full Text] [Related]  

  • 36. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cladinose analogues of sixteen-membered macrolide antibiotics. I. Synthesis of 4-O-alkyl-L-cladinose analogues via glycosylation.
    Kurihara K; Ajito K; Shibahara S; Ishizuka T; Hara O; Araake M; Omoto S
    J Antibiot (Tokyo); 1996 Jun; 49(6):582-92. PubMed ID: 8698643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 16-membered macrolides modified at C-12 and C-13 positions of midecamycin A1 and miokamycin. Part 1: Synthesis and evaluation of 12,13-carbamate and 12-arylalkylamino-13-hydroxy analogues.
    Miura T; Kurihara K; Furuuchi T; Yoshida T; Ajito K
    Bioorg Med Chem; 2008 Apr; 16(7):3985-4002. PubMed ID: 18258437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.